@@claudek Did the same, bought a alittle at $0.45.I am a trader...

@@claudek Did the same, bought a alittle at $0.45.

I am a trader at heart. I don't have to like management. I just have to see value and that they will progress the company....eventually. Like them or not, mamagement has progressed regulatory approval and commercialisation, albeit far slower than we would have liked.

Ask yourself this. If you were not already invested in OCC (and hurting from these continual management disappointment share moves) would you not look at this company and go whay the hell is this trading so cheaply? It is FDA/TPG/EMA approved in one application of its product. It will be in another application in the next six months or so and a third in the next year or two.

It has a revolutionary treatment that it is trialling with the largest Pharmaceutical company in the world that has a huge potential market. Its late (again) on results, but they are done on the trial, we know that.